HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Autoimmune hepatitis and primary sclerosing cholangitis in children and adolescents.

AbstractUNLABELLED:
Clinical presentation and histopathology of autoimmune hepatitis (AIH) and primary sclerosing cholangitis (PSC) overlap syndrome (OS) are similar, but their management is different. We conducted a pediatric retrospective cross-sectional study of 34 patients with AIH and PSC. AIH had female predominance (74%) and was lower in PSC (45%). There was a trend toward higher frequency of blacks in PSC/OS (55%) compared to Caucasians (36%) and Hispanics (9%), but not race differences in AIH. Inflammatory bowel disease (IBD) was present in 75% of PSC/OS. Plasma cells were not specific for AIH (found in 42% of PSC). Concentric fibrosis was not reliable for PSC as was found in 46% of AIH.
CONCLUSION:
A combination of clinical history, laboratory tests, imaging studies and liver biopsy are required to confirm and properly treat AIH and PSC. Liver biopsy should be used to grade severity and disease progression, but cannot be used alone to diagnose these conditions.
AuthorsClaudia Patricia Rojas, Rajasekhar Bodicharla, German Campuzano-Zuluaga, Lina Hernandez, Maria Matilde Rodriguez
JournalFetal and pediatric pathology (Fetal Pediatr Pathol) Vol. 33 Issue 4 Pg. 202-9 (Aug 2014) ISSN: 1551-3823 [Electronic] England
PMID24754367 (Publication Type: Journal Article)
Chemical References
  • Autoantibodies
  • gamma-Glutamyltransferase
  • gamma-glutamyltransferase, human
  • Aspartate Aminotransferases
  • Alanine Transaminase
Topics
  • Adolescent
  • Alanine Transaminase (blood)
  • Aspartate Aminotransferases (blood)
  • Autoantibodies (blood)
  • Child
  • Child, Preschool
  • Cholangitis, Sclerosing (blood, diagnosis, pathology)
  • Cross-Sectional Studies
  • Diagnosis, Differential
  • Female
  • Hepatitis, Autoimmune (blood, diagnosis, pathology)
  • Humans
  • Liver (pathology)
  • Male
  • Retrospective Studies
  • gamma-Glutamyltransferase (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: